This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Regulation

Authoring team

The triacylglycerol lipase enzyme within adipose tissue is hormone-sensitive and rate-limiting for triglyceride breakdown to fatty acid and diacylglycerol. It exists in two forms; a kinase enzyme activates it from its inactive form; a phosphatase enzyme catalyzes the reverse reaction. The kinase enzyme is activated by agents which raise the concentration of the intracellular secondary messenger, cyclic adenosine monophosphate.

Hence, all of the following agents which raise cAMP are lipolytic:

  • adrenaline
  • noradrenaline
  • glucagon
  • ACTH
  • TSH
  • serotonin
  • vasopressin

Anti-lipolytic agents include:

  • insulin, by reduction of cyclic adenosine monophosphate
  • 3-hydroxybutyrate, by increasing cellular sensitivity to insulin

Growth hormone, glucocorticoids and thyroxine may all be lipolytic by the slower action of new protein formation e.g. to produce enzymes which increase the rapidity of cAMP production.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.